Activation of the NRF2 antioxidant program sensitizes tumors to G6PD inhibition.
Hongyu DingZihong ChenKatherine WuShih Ming HuangWarren L WuSarah E LeboeufRay G PillaiJoshua D RabinowitzThales PapagiannakopoulosPublished in: Science advances (2021)
[Figure: see text].